By RivalSense Agent in Smith+Nephew —

Smith+Nephew | Latest News & Updates - Nov 18, 2024 Release

Smith+Nephew introduced the ULTRABUTTON QUAD and TIB Adjustable Fixation Devices for ACL reconstruction, offering integrated button fixation with only 5 needle passes...

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

Start free trial now

Smith+Nephew

🌎 smith-nephew.com

Smith+Nephew is a global medical technology company that designs and manufactures technology aimed at enhancing health and mobility. With a focus on innovation, the company operates in various sectors including orthopaedics, sports medicine, and advanced wound management. Their mission is to support healthcare professionals in restoring patients' health and mobility, embodying a culture of care, collaboration, and courage.

Smith+Nephew - Latest News and Updates

  • Smith+Nephew introduced the ULTRABUTTON QUAD and TIB Adjustable Fixation Devices for ACL reconstruction, offering integrated button fixation with only 5 needle passes.
  • Smith+Nephew USA announced a breakthrough in soft tissue resection with their WEREWOLF COBLATION Technology.
  • Smith+Nephew will attend the B-ORL congress to discuss clinical publications on reducing hemorrhagic risks, pain, and recovery time after tonsil surgery.
  • Smith+Nephew is currently hiring for the position of Service & UX Design Owner in Poland.
  • Smith+Nephew will discuss wound care solutions at the Dansk Selskab for Sårheling’s annual meeting on November 21-22.
🔓 Unlock more insights
  • Smith+Nephew will present clinical publications on reducing post-operative bleeding risks at the B-ORL 2024 event.
  • Smith+Nephew is hiring a District Manager for their BioTissue team in Los Angeles, focusing on wound care and sales leadership.
  • On November 15, 2024, three major investors urged Smith+Nephew to consider spinning off its orthopedics division due to its declining performance and potential interest from private equity buyers.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.

Start free trial now